Supplementation of docosahexaenoic acid (DHA) / Eicosapentaenoic acid (EPA) in a ratio of 1/1.3 during the last trimester of pregnancy results in EPA accumulation in cord blood


BÜYÜKUSLU N., Ovalı S., Altuntaş Ş. L., BATIREL S., YİĞİT P., Garipağaoğlu M.

Prostaglandins Leukotrienes and Essential Fatty Acids, cilt.125, ss.32-36, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 125
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.plefa.2017.08.005
  • Dergi Adı: Prostaglandins Leukotrienes and Essential Fatty Acids
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.32-36
  • Anahtar Kelimeler: Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA), Omega-3 fatty acids, Omega supplement, Pregnancy, Umbilical cord
  • İstanbul Medipol Üniversitesi Adresli: Evet

Özet

Omega-3 fatty acids (n-3 FA), specifically DHA, are associated with fetal growth and development. We aimed to determine the levels of DHA and EPA in cord serum after n-3 FA supplementation during the last trimester of pregnancy. Among 55 women, 23 were administered daily one capsule of n-3 FA supplement, involving DHA/EPA in a ratio of 1/1.3. Twenty nine women were enrolled as control group. Blood samples were collected at 22–24 weeks of gestation and at delivery. Fatty acids were analyzed with the method of GC-MS. Cord DHA level increased and EPA level decreased in both groups between the days of 22–24 and delivery. However, decrease in cord EPA level was significant in control group (p < 0.001) but not in supplement group (p > 0.05). Supplementation of DHA/EPA in a ratio of 1/1.3 during the last trimester of pregnancy caused higher cord EPA level compared to control group indicating an accumulation in umbilical cord.